Special items: Ovarian Cancer and Us blog best viewed in Firefox
▼
Monday, August 22, 2011
full free access: PLoS Medicine: How Industry Uses the ICMJE Guidelines to Manipulate Authorship—And How They Should Be Revised
"The ICMJE guidelines will always be a work in progress, but the
adjustments proposed here have the potential to end the self-concealment
and authorial misrepresentations that mar industry's contributions to
the literature. Furthermore, they have the potential to help industry
achieve the enhanced respect its beneficial contributions to medicine
deserve. Industry publications will always have a commercial valence
alongside their scientific and medical content: this should henceforth
be truthfully displayed, and no longer downplayed or concealed."
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.